SAGA Diagnostics is a personalized cancer genomics and disease monitoring company that offers molecular genetic testing of liquid biopsies. SAGAsafe® is part of a portfolio of ultrasensitive technologies, which also includes SAGAsign® for personalized monitoring of cancer burden using chromosomal rearrangements, as well as novel technologies in development. SAGA helps pharmaceutical companies, scientists, and healthcare providers to detect actionable mutations, stratify patient groups, and monitor treatment response more accurately and to an industry-leading lower limit of detection of 0.001%.
Visit sagadiagnostics.com for more information.
SAGAsafe EGFR T790M CE-marked